Gavestinel
Gavestinel[edit]
Gavestinel is a chemical compound that acts as a selective antagonist of the NMDA receptor, specifically targeting the glycine site of the receptor. It was investigated for its potential use in the treatment of stroke and other neurological disorders.
Mechanism of Action[edit]
Gavestinel functions by inhibiting the activity of the NMDA receptor, a type of glutamate receptor that plays a crucial role in synaptic plasticity and neurotransmission. By blocking the glycine site, Gavestinel reduces the excitotoxicity associated with excessive NMDA receptor activation, which is a common pathological feature in conditions such as stroke.
Clinical Development[edit]
Gavestinel was developed as a neuroprotective agent with the aim of reducing brain damage following an acute ischemic stroke. Despite promising preclinical results, clinical trials did not demonstrate significant efficacy in improving outcomes for stroke patients. As a result, its development for this indication was discontinued.
Pharmacokinetics[edit]
The pharmacokinetic profile of Gavestinel includes its absorption, distribution, metabolism, and excretion. It is known to cross the blood-brain barrier, which is essential for its action on central nervous system targets. However, specific details on its half-life and metabolic pathways are less documented in the literature.
Potential Applications[edit]
Although Gavestinel was not successful in clinical trials for stroke, its mechanism of action suggests potential applications in other neurological conditions where NMDA receptor-mediated excitotoxicity is implicated, such as traumatic brain injury and certain types of epilepsy.
See Also[edit]
Related Pages[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
